Celiac genetic testing: what HLA-DQ2 and DQ8 results can and cannot tell you
Short answer
Celiac genetic testing looks for the DQ2 and DQ8 gene variants1. Its informative result is a negative15: NIDDK says people without them are very unlikely to have celiac disease1. A positive does not diagnose it4: NIDDK puts the share of people with DQ2 or DQ8 at about 30 percent, and only about 3 percent of them develop celiac disease2.
Part of Celiac genetics and family risk, 15 guides

Key points
- A negative HLA-DQ2/DQ8 result is the informative one, in GIG's words15: NIDDK says people without the variants are very unlikely to have celiac disease, and ACG says that if the test is negative, celiac disease is ruled out1, 3.
- A positive result does not diagnose celiac disease: NIDDK says most people with DQ2 or DQ8 do not develop it4.
- No source we read recommends typing the general population: Coeliac UK says typing the general population is not recommended or currently practised, and ACG says the test is not required for diagnosis in all cases5, 3.
- ESPGHAN's 2020 guideline made HLA typing a non-obligatory criterion in its no-biopsy route for children6.
- People who started a gluten-free diet before testing are one place ACG names HLA typing: it calls it central, and says a gluten challenge can be offered if a compatible haplotype is found3.
What HLA typing reads
NIDDK describes the test this way: in some cases a health care professional may take a blood sample or use a cheek swab, and the sample is tested for groups of gene variants called DQ2 and DQ81. NIDDK says celiac disease almost always occurs in people who have one of the two groups7.
Coeliac UK, writing for healthcare professionals, names the types in more detail. In patients with celiac disease the commonest are DQ2.5 (highest risk), then DQ8 (moderate risk), then DQ2.2 (low risk, but not no risk)8.
NIDDK says doctors most often use blood tests and biopsies of the small intestine to diagnose or rule out celiac disease9, and that genetic tests are among the additional tests they may order in some cases10.
The method matters. ESPGHAN notes that SNP-based tests recognize the common variants (DQ2.5, DQ8, DQ2.2, DQ7.5), that in-depth allele typing is needed to identify rare variants, and that the accuracy of HLA testing for excluding celiac disease still depends on the method used11.
Reading a negative result
The sources below all read a negative result as pointing away from celiac disease. Each words it a little differently, so the table keeps each source's own wording and scope.
| Source | What it says about a negative result |
|---|---|
| NIDDK (US) | People without the DQ2 and DQ8 variants are “very unlikely” to have celiac disease1. |
| ACG guideline, 2023 (US) | “If negative, CD is ruled out.” ACG places the test in selected situations, such as a serology-histology discrepancy, meaning blood and biopsy findings that do not match3. |
| ESPGHAN guideline, 2020 (children) | If a patient tests negative for HLA DQ2 and DQ8, “the risk of CD is very low”12. |
| WGO guideline, 2016 | HLA typing has a high negative predictive value, and an absence of HLA-DQ2/-DQ8 excludes the presence of celiac disease in susceptible individuals13. |
| Coeliac UK (UK) | Being negative “would be very reassuring”, though “never a guarantee”, and there are “very rare patients” who carry none of DQ2.5, DQ8 or DQ2.214. |
| Gluten Intolerance Group (GIG) | GIG says negative results tell a person that it is “virtually impossible” that they have, or will develop, celiac disease15. |
Where the sources put a number on the exceptions, it is small. Coeliac UK says 99.6% of patients with celiac disease carry DQ2.5, DQ8 or DQ2.216. WGO says fewer than 1% of patients lack DQ2 and DQ817. ESPGHAN cites an Australasian celiac disease population of 356 in which 99.6% were DQ2/DQ8-positive, and says it may be concluded that the higher percentage of DQ2/DQ8-negative patients in earlier publications (up to 5%) had several causes, one being the HLA testing method18.
A negative result speaks to the genes celiac disease almost always occurs with7. It does not speak to non-celiac gluten sensitivity: GIG says the test does not shed any light on whether a person has it19.
Reading a positive result
NIDDK is direct about it: having DQ2 or DQ8 alone does not mean you have celiac disease, most people with these gene variants do not develop it, and a doctor may recommend additional tests to check for or rule out celiac disease4.
The reason is how common the gene types are. The sources give different figures, so the table reports each as its owner states it.
| Source | Gene types in the general population | Celiac disease, as the source puts it |
|---|---|---|
| NIDDK (US) | About 30 percent of people have DQ2 or DQ82 | Only about 3 percent of people with DQ2 or DQ8 develop celiac disease2 |
| WGO, 2016 | 30–35% in the general population20 | Prevalence varies between roughly one in 100 and one in 300 in most parts of the world21 |
| Coeliac UK (UK) | DQ2 and DQ8 haplotypes found in up to 40%22 | Estimated prevalence in the UK is 1%22 |
| GIG | About a third of the general population carries the genes15 | Only one percent develops celiac disease15 |
Coeliac UK says that for a patient with suspected celiac disease who is not responding to a gluten-free diet, a positive result does not diagnose celiac disease and is “not very helpful”, because so many people in the general population are DQ positive without having it23. For a child with no symptoms and an at-risk condition such as type 1 diabetes, it says a positive result only shows the child has the type that may permit celiac disease; antibody testing matters if the child is eating gluten, and if the antibody test is also positive, celiac disease is likely and some children need an endoscopy and biopsy to confirm24.
Gluten stays part of the picture. WGO says there is no celiac disease without gluten, even in the presence of a genetic predisposition25, and NIDDK says not all people who have DQ2 or DQ8 and eat gluten develop the disease26.
Where the guidelines place the test
No source we read recommends HLA typing for the general population. Coeliac UK says typing the general population is not recommended or currently practised, and that practice is to use it in specific at-risk scenarios, primarily looking to exclude the condition5.
| Source | Where it places the test |
|---|---|
| NIDDK (US) | Genetic tests are among the additional tests doctors may order “in some cases”10. |
| ACG guideline, 2023 (US) | Not required for diagnosis in all cases; may be helpful in selected situations such as a serology-histology discrepancy; central to the approach for people who started a gluten-free diet before evaluation3. |
| ESPGHAN guideline, 2020 (children) | Not required in a patient with positive TGA-IgA who qualifies for diagnosis with biopsies, or who has high TGA-IgA (10 times the upper limit of normal or more) and positive EMA-IgA12; may be useful in other circumstances27. |
| WGO guideline, 2016 | Its list of situations names exclusion of celiac disease, an uncertain diagnosis (negative serology but suggestive histology, where typing helps only if negative), siblings, and people with other autoimmune diseases or some genetic disorders28. It also says genotyping may be important in seronegative disease and before a formal gluten challenge29. |
| Coeliac UK (UK) | Not routinely recommended in the diagnosis pathway, but it can have an important role in ruling out people who will not likely (or never) need future testing, and may allow a risk assessment for those with the appropriate HLA types30. |
Why ESPGHAN no longer requires HLA typing in the children’s no-biopsy route
ESPGHAN's 2012 recommendations for a no-biopsy approach included testing for HLA-DQ2 and DQ8 in individuals with very high TGA-IgA titres and EMA-IgA positivity31. The 2020 guideline says HLA DQ2/DQ8 determination, like symptoms, is not an obligatory criterion6.
The guideline gives its reasons. It reviews one study of 645 paediatric patients in which 399 met the no-biopsy criteria, all 399 were positive for DQ2 and/or DQ8, and it was concluded that HLA typing did not add to the certainty of the diagnosis in these patients32. It also says HLA testing is not universally available and is quite costly in some countries, so if it does not improve the no-biopsy diagnosis it should be omitted33.
Coeliac UK reported the change as genetic testing no longer being required for children with high antibody levels34. It quotes Dr Peter Gillett, a consultant paediatric gastroenterologist: “Diagnosis can now be based on two antibody blood tests without the need for genetic testing”35. ACG's 2023 guideline says the updated 2020 ESPGHAN guidelines proposed that HLA testing is no longer necessary36.
The change is about the antibody-based route for children with high antibody levels. It does not take HLA typing out of the situations in the previous section: ESPGHAN's statement still says testing for HLA DQ2 and DQ8 may be useful in other circumstances27.
Relatives and at-risk groups
NIDDK says blood relatives of people with celiac disease, and people with type 1 diabetes, should talk with their doctor about their chances of getting the disease to see if they should be tested37.
Two sources put figures on families. GIG says prevalence in first-degree relatives ranges from 4% to 16%, and is about 2.5% in second-degree relatives38. WGO says approximately 70% of first-degree relatives are HLA-DQ2- and/or HLA-DQ8-positive, against 30–35% in the general population20.
The sources differ in how they bring genes in. WGO's section on first-degree relatives includes the line “HLA typing for all first-degree relatives; do no further work-up on those who are negative for HLA-DQ2/8”39. Coeliac UK says HLA DQ2 and 8 typing is suggested in guidance as helpful in excluding people from future testing in at-risk groups, with first-degree relatives and Down syndrome as examples40. ESPGHAN says that for some at-risk groups, such as type 1 diabetes, typing may not be cost-effective because of the high percentage of HLA positives, but may be in others, for example first-degree relatives or Down syndrome41.
For parents who have celiac disease and want to know whether their children could develop it, GIG, in a 2019 FAQ, says positive genetic tests mean monitoring should be ongoing and negative tests mean no further screening is necessary42. ACG's guideline separately says patients with a first-degree family member who has a confirmed diagnosis should be tested for celiac disease43. How a family combines gene and antibody tests is a decision for their clinician.
When gluten has already been dropped
NIDDK says doctors do not recommend starting a gluten-free diet before diagnostic testing, because the diet can affect test results9. WGO says celiac disease should be excluded by a negative test for celiac-specific antibodies before anyone starts the diet for any reason44. GIG says testing before giving up gluten is always advisable, but that this does not always happen45.
For people who did stop first, the sources name HLA typing. ACG calls it central to the approach, and says that in the presence of a compatible haplotype a gluten challenge can be offered3. WGO says genotyping may be important in seronegative disease and to exclude celiac disease before a formal gluten challenge29. Coeliac UK describes a patient who went gluten-free without a diagnosis and then cannot tolerate reintroducing gluten, or starts a challenge, where the medical team performs HLA typing on clinical suspicion, and says some patients choose a commercial test and look for an explanation of the results46. For a patient with suspected celiac disease who is not responding to a gluten-free diet, it says that if the patient tests negative for DQ2.5, DQ8 or DQ2.2, it could be stated with confidence that the patient does not have celiac disease47.
A positive result in this situation leads to the next step, not to a diagnosis: ACG's text offers a gluten challenge when a compatible haplotype is found3.
Who orders it and what the report shows
The only source we read that describes ordering is Coeliac UK, and it describes the UK:
- Typing is widely available, cost varies considerably from laboratory to laboratory, and the format of the reporting is not standardised48.
- Such testing generally goes through secondary care, by paediatricians or gastroenterologists with an interest in celiac disease or by specialist dietitians48.
A result sheet can be read against those points: which of DQ2.5, DQ8 and DQ2.2 was reported8, which method the lab used11, and whether the result is being used to rule out or to assess risk30. For the difference between a consumer genetic test and clinical HLA typing, see 23andMe vs clinical HLA typing; for the antibody tests, see the celiac blood test guide.
Questions people ask
Does a positive celiac gene test mean I have celiac disease?
No. NIDDK says having DQ2 or DQ8 alone does not mean you have celiac disease, and that most people with these gene variants do not develop it4.
Can I have celiac disease with a negative gene test?
The sources treat it as very unlikely: NIDDK says “very unlikely”1 and ACG says celiac disease is ruled out3. Coeliac UK notes there are very rare patients who carry none of DQ2.5, DQ8 or DQ2.214.
Is genetic testing needed to diagnose celiac disease?
Not in every case. ACG says it is not required for diagnosis in all cases3, ESPGHAN says HLA typing is not an obligatory criterion for its no-biopsy diagnosis in children6, and Coeliac UK says it is not routinely recommended in the diagnosis pathway30.
More in Celiac genetics and family risk
Celiac genetic test results in the US: who can see them, and what the law coversWhat US law covers when a genetic test result exists, such as a celiac HLA result: health insurance, jobs, the gaps, and a test company's policy.
23andMe versus a clinical HLA test for celiac disease: what each reads and what a negative meansWhich gene variants the FDA-authorized 23andMe celiac report and clinical HLA typing read, and how labs and charities describe a negative or positive.
HLA-DQ2 and HLA-DQ8 explained: the allele names on a celiac gene reportWhat DQA1, DQB1, DQ2.5, DQ2.2 and DQ8 mean on a celiac gene report, how often each appears in celiac disease, and how common they are overall.
A positive celiac gene test in your child: what it means and what happens nextWhat a positive HLA (DQ2 or DQ8) result in a child means, why sources say gluten stays in the diet until testing, and what clinicians check next.
Gone gluten-free without testing: what an HLA gene test can settleWhat an HLA-DQ2/DQ8 gene test can and cannot settle if you stopped gluten before celiac testing, and what sources say a gluten challenge involves.
Celiac disease genes beyond HLA: what large genetic studies foundWhat large genetic studies found beyond HLA in celiac disease, how much of the inherited risk those regions explain, and whether clinical tests cover them.
Related guides
Celiac Blood Tests: What tTG-IgA, Total IgA, DGP and EMA Each CheckWhat tTG-IgA, total IgA, EMA and DGP check, why total IgA is drawn with tTG-IgA, when back-up tests are used, and why gluten stays in the diet first.
At-home celiac and gluten sensitivity tests: what they can and cannot showWhat home celiac antibody kits, IgG food panels, stool and genetic tests can and cannot show, and what a result still needs from a clinician.
Reading a tTG-IgA result: cutoffs, borderline results and lab differencesWhat the number, cutoff and flag on a tTG-IgA report mean, why labs differ, and where guidelines draw the line at 10 times the upper limit of normal.
Celiac disease symptoms in children, and who pediatric guidelines say to testTypical and less typical celiac signs in children, who pediatric guidelines say to test, and why the child keeps eating gluten until testing ends.
Sources
- [1, 4, 9, 10, 37] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Diagnosis of Celiac Disease, checked Nov 17, 2026.
- [2, 7, 26] National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Symptoms & Causes of Celiac Disease, checked Nov 17, 2026.
- [3, 36, 43] American College of Gastroenterology (American Journal of Gastroenterology), ACG Clinical Guidelines Update: Diagnosis and Management of Celiac Disease (Rubio-Tapia et al., 2023), checked Nov 17, 2026.
- [5, 8, 14, 16, 22, 23, 24, 30, 40, 46, 47, 48] Coeliac UK, Genetics (healthcare professionals: diagnosis), checked Nov 17, 2026.
- [6, 11, 12, 18, 27, 31, 32, 33, 41] ESPGHAN (Journal of Pediatric Gastroenterology and Nutrition), European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020 (Husby et al.), checked Nov 17, 2026.
- [13, 17, 20, 21, 25, 28, 29, 39, 44] World Gastroenterology Organisation, World Gastroenterology Organisation Global Guidelines: Celiac Disease (long version, July 2016), checked Nov 17, 2026.
Read on 2026-11-17: the list headed “HLA tests are recommended in the following situations” names a negative HLA test to exclude the possibility of celiac disease; an uncertain diagnosis (negative serology but histology suggestive of celiac disease), where HLA testing is helpful only if it is negative; distinguishing siblings who can be reassured that celiac disease is unlikely from those who need monitoring; and individuals with other autoimmune diseases and some genetic disorders who should be investigated for celiac disease (for example autoimmune thyroiditis).
- [15, 19, 38, 42, 45, 49] Gluten Intolerance Group, What is the relevance of genetic testing in the gluten-free world?, checked Nov 17, 2026.
- [34, 35] Coeliac UK, Genetic testing removed from guidelines for diagnosis of CD in children, checked Nov 17, 2026.